Literature DB >> 18059140

Identification of molecular markers for the oncogenic differentiation of hepatocellular carcinoma.

Gyung Ran Yu1, Seong Hun Kim, Seon Hwa Park, Xiang Dan Cui, Dong Yuan Xu, Hee Chul Yu, Baik Hwan Cho, Young Il Yeom, Sang Soo Kim, Sang Bae Kim, In Sun Chu, Dae Ghon Kim.   

Abstract

The aim of this study was to identify molecular markers associated with oncogenic differentiation in hepatocellular carcinoma (HCC). Using an unsupervised clustering method with a cDNA microarray, HCC (T) gene expression profiles and corresponding non-tumor tissues (NT) from 40 patients were analyzed. Of total 217 genes, 72 were expressed preferentially in HCC tissues. Among 186 differentially regulated genes, there were molecular chaperone and tumor suppressor gene clusters in the Edmondson grades I and II (GI/II) subclass compared with the liver cirrhosis (LC) subclass. The Edmondson grades III and IV (GIII/IV) subclass with a poor survival (P=0.0133) contained 122 differentially regulated genes with a cluster containing various metastasis- and invasion-related genes compared with the GI/II subclass. Immunohistochemical analysis revealed that ANXA2, one of the 72 genes preferentially expressed in HCC, was over-expressed in the sinusoidal endothelium and in malignant hepatocytes in HCC. The genes identified in the HCC subclasses will be useful molecular markers for the genesis and progression of HCC. In addition, ANXA2 might be a novel marker for tumor angiogenesis in HCC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18059140     DOI: 10.1038/emm.2007.70

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  19 in total

1.  Clinicopathological significance of NGX6 expression in breast cancer and its relationship to angiogenesis.

Authors:  Jidong Xiao; Yuyao Mao; Yuanquan Zhou; Kaimin Xiang
Journal:  Int J Clin Exp Med       Date:  2015-12-15

2.  Transcriptional modules related to hepatocellular carcinoma survival: coexpression network analysis.

Authors:  Xinsen Xu; Yanyan Zhou; Runchen Miao; Wei Chen; Kai Qu; Qing Pang; Chang Liu
Journal:  Front Med       Date:  2016-04-06       Impact factor: 4.592

3.  Custom design of a GeXP multiplexed assay used to assess expression profiles of inflammatory gene targets in normal colon, polyp, and tumor tissue.

Authors:  Janice E Drew; Claus-Dieter Mayer; Andrew J Farquharson; Pauline Young; Lawrence N Barrera
Journal:  J Mol Diagn       Date:  2011-03       Impact factor: 5.568

4.  Clinicopathological predictors of poor survival and recurrence after curative resection in hepatocellular carcinoma without portal vein tumor thrombosis.

Authors:  Li Zhou; Jing-An Rui; Shao-Bin Wang; Shu-Guang Chen; Qiang Qu
Journal:  Pathol Oncol Res       Date:  2014-06-08       Impact factor: 3.201

5.  Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects.

Authors:  Kamala Kesavan; Judson Ratliff; Eric W Johnson; William Dahlberg; John M Asara; Preeti Misra; John V Frangioni; Douglas B Jacoby
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

6.  A novel biomarker TERTmRNA is applicable for early detection of hepatoma.

Authors:  Norimasa Miura; Yukio Osaki; Miki Nagashima; Michimori Kohno; Kensho Yorozu; Kohei Shomori; Takamasa Kanbe; Kenji Oyama; Yukihiro Kishimoto; Shigeo Maruyama; Eijiro Noma; Yutaka Horie; Masatoshi Kudo; Seigo Sakaguchi; Yasuaki Hirooka; Hisao Ito; Hironaka Kawasaki; Junichi Hasegawa; Goshi Shiota
Journal:  BMC Gastroenterol       Date:  2010-05-18       Impact factor: 3.067

7.  Protein expression profiling of vascular endothelial growth factor and its receptors identifies subclasses of hepatocellular carcinoma and predicts survival.

Authors:  Jin-Bin Jia; Peng-Yuan Zhuang; Hui-Chuan Sun; Ju-Bo Zhang; Wei Zhang; Xiao-Dong Zhu; Yu-Quan Xiong; Hua-Xiang Xu; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2008-12-10       Impact factor: 4.553

8.  The association of annexin A2 and cancers.

Authors:  Xiaohui Zhang; Shuqing Liu; Chunmei Guo; Junwei Zong; Ming-Zhong Sun
Journal:  Clin Transl Oncol       Date:  2012-07-24       Impact factor: 3.405

9.  Microarray-based gene expression analysis of hepatocellular carcinoma.

Authors:  Thorsten Maass; Ioannis Sfakianakis; Frank Staib; Markus Krupp; Peter R Galle; Andreas Teufel
Journal:  Curr Genomics       Date:  2010-06       Impact factor: 2.236

10.  Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma.

Authors:  Yulin Sun; Guangzhou Gao; Jianqiang Cai; Youliang Wang; Xiuhua Qu; Lidong He; Fang Liu; Yangjun Zhang; Kaixuan Lin; Shouzhi Ma; Xiao Yang; Xiaohong Qian; Xiaohang Zhao
Journal:  Carcinogenesis       Date:  2012-11-27       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.